CNBC June 27, 2024
Annika Kim Constantino

Key Points

– Walgreens reported fiscal third-quarter earnings that fell short of expectations and slashed its full-year adjusted profit outlook due to a “challenging” environment for pharmacies and U.S. consumers.

– The company topped revenue estimates for the quarter on strong performance in its health-care segment.

– The results come as Walgreens works to slash costs by closing underperforming U.S. stores, among other efforts.

Shares of Walgreens plunged more than 20% on Thursday after the company reported fiscal third-quarter earnings that fell short of expectations and slashed its full-year adjusted profit outlook, citing a “challenging” environment for pharmacies and U.S. consumers.

The retail pharmacy giant now expects fiscal 2024 adjusted earnings of $2.80 to $2.95 per share. That compares...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma, Pharma / Biotech, Provider, Retailer
Google DeepMind CEO: AI-Designed Drugs Coming to Clinical Trials in 2025
DOJ Accuses Walgreens of Filling Millions of Illegitimate Prescriptions
DOJ sues Walgreens for allegedly filling millions of illegal prescriptions, including opioids
Q&A: NCPA Announces Independent Community Pharmacy Consortium for Government Engagement
Texas system looks to expand central pharmacy capacity: 4 notes

Share This Article